Checkmate Pharmaceuticals, Inc.: current_assets
| Value | {"amount": 102101000, "concept": "us-gaap:AssetsCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | Checkmate Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:00:28.648796+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/df7554ee-5eec-414e-8ac0-741c6cb85b74
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-21-098414 · Open the official SEC filing →Retrieved: 2026-08-19T17:00:28.648796+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001651431/current-assets/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/df7554ee-5eec-414e-8ac0-741c6cb85b74
History
- no predecessors — first report